By Tom Whicher, CEO, DrDoctor No doubt delegates at this year’s Digital Health Rewired event will be looking for tangible returns on investment, especially now that the familiar downward pressure on NHS tech funding is…
Continue Reading
What You Should Know:– COTA, Inc., an oncology real-world data and analytics company, today announced a new partnership with Genomic Testing Cooperative (GTC), a molecular testing company.– GTC has a very innovative approach to genetic testing,…
Continue Reading
Looking at industrial development eras in the history of humanity, the world experienced four industrial revolutions starting with the industry 1.0 revolution by the end of the 18th century where we saw the use…
Continue Reading
Chroma Medicine, a biotech company developing therapies that turn genes on or off as a way of treating genetic disorders, has raised $135 million as it works to generate data that could show the…
Continue Reading
By Mark Melchionna
March 02, 2023 – Recent research from Rutgers, the State University of New Jersey, described how artificial intelligence (AI) and machine learning (ML) could be used to examine genes within DNA,…
Dr Rocío Acuña Hidalgo, co-founder and CTO at Nostos GenomicsThe sequencing and analysis of human DNA have advanced significantly since the initial draft of a human genome that was published as part of the…
Continue Reading
The vast majority of the critically essential secrets in biology are hidden from researchers. The human microbiome is now considered a human organ, yet the word “microbiome” was not in the research lexicon as…
Continue Reading
What You Should Know:– Tempus, the $10B artificial intelligence and precision medicine company, announced their first multi-omics collaboration with Actuate Therapeutics, in which datasets of different omic groups – genomics, transcriptomics, epigenomics, and others…
Continue Reading
Moderna’s ambitions in messenger RNA technology include therapies that do their editing work inside the patient. To that end, the biotech company is starting an R&D collaboration with a division of ElevateBio that brings…
Continue Reading
Heather Bassett, M.D., Chief Medical Officer, XSOLISToday’s relationship between payers and providers is more fraught than ever. With a history of transactional, often adversarial, fee-for-service contract negotiations, it’s no wonder that the healthcare industry…
Continue Reading
